| 2009-03-02 |
| Immunicum's CEO, Jamal El-Mosleh, holds a company presentation at UK-Nordic Oncology Conference in Copenhagen. UK-Nordic Oncology Conference showcases interesting Nordic companies focusing on cancer and provides networking opportunities for strategic alliances within the field of oncology. Keynote speakers include representatives from companies such as AstraZeneca and GlaxoSmithKline. Company presenters include speakers from Bavarian Nordic, Symphogen, Active Biotech, and TopoTarget. |
